Prevalence and Natural History of Colonization With Fluoroquinolone-Resistant Gram-Negative Bacilli in Community-Dwelling People With Spinal Cord Dysfunction

Archives of Physical Medicine and Rehabilitation

Volumn 87, Issue 10, 2006, Pages 1305-1309

  Roghmann, Mary Claire ^a   Wallin, Mitchell T ^b   Gorman, Peter H ^a   Johnson, Judith A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti infective agents, fluoroquinolone; Antibiotic resistance; Cross sectional study; Multiple sclerosis; Rehabilitation; Spinal cord injuries; Urinary tract infections

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; COTRIMOXAZOLE; GATIFLOXACIN; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; COHORT ANALYSIS; COMMUNITY LIVING; CONDOM CATHETER; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HISTORY; HUMAN; INCONTINENCE; INFECTION RISK; INTERMITTENT CATHETERIZATION; MAJOR CLINICAL STUDY; MALE; PERINEUM; PREVALENCE; RISK FACTOR; SPINAL CORD INJURY; STATISTICAL SIGNIFICANCE; SUPRAPUBIC CATHETER; URINARY TRACT INFECTION; URINE CATHETER;

ANTI-BACTERIAL AGENTS; CARRIER STATE; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; FLUOROQUINOLONES; GRAM-NEGATIVE AEROBIC BACTERIA; HUMANS; MALE; MIDDLE AGED; OFLOXACIN; PERINEUM; PREVALENCE; PROSPECTIVE STUDIES; SPINAL CORD DISEASES; URINARY CATHETERIZATION; URINARY INCONTINENCE; URINARY TRACT INFECTIONS;

EID: 33749129156     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apmr.2006.07.260     Document Type: Article

References (16)

1. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control 31 (2003) 481-498
2. Lautenbach E., Strom B.L., Nachamkin I., et al. Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organisms. Clin Infect Dis 38 (2004) 655-662
3. Montgomerie J.Z. Infections in patients with spinal cord injuries. Clin Infect Dis 25 (1997) 1285-1290
4. Hinkel A., Finke W., Botel U., Gatermann S.G., and Pannek J. Increasing resistance against antibiotics in bacteria isolated from the lower urinary tract of an outpatient population of spinal cord injury patients. Urol Int 73 (2004) 143-148
5. Penders J., Huylenbroeck A.A., Everaert K., Van Laere M., and Verschraegen G.L. Urinary infections in patients with spinal cord injury. Spinal Cord 41 (2003) 549-552
6. Mylotte J.M., Kahler L., Graham R., Young L., and Goodnough S. Prospective surveillance for antibiotic-resistant organisms in patients with spinal cord injury admitted to an acute rehabilitation unit. Am J Infect Control 28 (2000) 291-297
7. Mylotte J.M., Graham R., Kahler L., Young L., and Goodnough S. Epidemiology of nosocomial infection and resistant organisms in patients admitted for the first time to an acute rehabilitation unit. Clin Infect Dis 30 (2000) 425-432
8. Waites K.B., Chen Y., DeVivo M.J., Canupp K.C., and Moser S.A. Antimicrobial resistance in gram-negative bacteria isolated from the urinary tract in community-residing persons with spinal cord injury. Arch Phys Med Rehabil 81 (2000) 764-769
9. Dow G., Rao P., Harding G., et al. A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury. Clin Infect Dis 39 (2004) 658-664
10. Multiple Sclerosis Council for Clinical Practice Guidelines. Urinary dysfunction and multiple sclerosis (1999), National Multiple Sclerosis Society, New York
11. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
12. Lublin F.D., and Reingold S.C. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46 (1996) 907-911
13. American Spinal Injury Association, International Medical Society of Paraplegia. Standard neurological classification of spinal cord injury (2002), ASIA/IMSOP, Chicago
14. Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing (2006), National Committee for Clinical Laboratory Standards, Wayne
15. Gimber E.A., Shields M.D., Canawati H.N., et al. Bacteriuria with Escherichia coli resistant to ciprofloxacin in patients with spinal-cord injury [letter]. Infect Control Hosp Epidemiol 19 (1998) 85-86
16. Waites K.B., Canupp K.C., Brookings E.S., and DeVivo M.J. Effect of oral ciprofloxacin on bacterial flora of perineum, urethra, and lower urinary tract in men with spinal cord injury. J Spinal Cord Med 22 (1999) 192-198